164 related articles for article (PubMed ID: 23036241)
21. Clinical pharmacokinetics: current requirements and future perspectives from a regulatory point of view.
Shah RR
Xenobiotica; 1993 Nov; 23(11):1159-93. PubMed ID: 8310705
[TBL] [Abstract][Full Text] [Related]
22. The effect of adult and pediatric cardiopulmonary bypass on pharmacokinetic and pharmacodynamic parameters.
van Saet A; de Wildt SN; Knibbe CA; Bogers AD; Stolker RJ; Tibboel D
Curr Clin Pharmacol; 2013 Nov; 8(4):297-318. PubMed ID: 23244246
[TBL] [Abstract][Full Text] [Related]
23. Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children.
Hines RN
Int J Pharm; 2013 Aug; 452(1-2):3-7. PubMed ID: 22766445
[TBL] [Abstract][Full Text] [Related]
24. Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics.
Brocks DR
Biopharm Drug Dispos; 2006 Nov; 27(8):387-406. PubMed ID: 16944450
[TBL] [Abstract][Full Text] [Related]
25. [Use of the labelling of drugs with stable isotopes in clinical pharmacology in children].
Pons G; Rey E; Badoual J; Olive G
Arch Fr Pediatr; 1989 Mar; 46(3):223-8. PubMed ID: 2660770
[TBL] [Abstract][Full Text] [Related]
26. Review on correlation between pharmacologic response and drug disposition.
Ritschel WA; Hussain A
Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):627-40. PubMed ID: 6392792
[TBL] [Abstract][Full Text] [Related]
27. Use of physiologically based pharmacokinetic modeling for assessment of drug-drug interactions.
Baneyx G; Fukushima Y; Parrott N
Future Med Chem; 2012 Apr; 4(5):681-93. PubMed ID: 22458685
[TBL] [Abstract][Full Text] [Related]
28. Dosing considerations in the pediatric patient.
Skaer TL
Clin Ther; 1991; 13(5):526-44; discussion 525. PubMed ID: 1799910
[TBL] [Abstract][Full Text] [Related]
29. Challenges and Opportunities for Increasing the Knowledge Base Related to Drug Biotransformation and Pharmacokinetics during Growth and Development.
Leeder JS; Meibohm B
Drug Metab Dispos; 2016 Jul; 44(7):916-23. PubMed ID: 27302933
[TBL] [Abstract][Full Text] [Related]
30. Study design and simulation approach.
Läer S; Meibohm B
Handb Exp Pharmacol; 2011; 205():125-48. PubMed ID: 21882109
[TBL] [Abstract][Full Text] [Related]
31. Pediatric pharmacokinetics and therapeutic drug monitoring.
McLeod HL; Evans WE
Pediatr Rev; 1992 Nov; 13(11):413-21. PubMed ID: 1289869
[TBL] [Abstract][Full Text] [Related]
32. A mechanistic approach to understanding oral drug absorption in pediatrics: an overview of fundamentals.
Debotton N; Dahan A
Drug Discov Today; 2014 Sep; 19(9):1322-36. PubMed ID: 24846709
[TBL] [Abstract][Full Text] [Related]
33. Improving pediatric dosing through pediatric initiatives: what we have learned.
Rodriguez W; Selen A; Avant D; Chaurasia C; Crescenzi T; Gieser G; Di Giacinto J; Huang SM; Lee P; Mathis L; Murphy D; Murphy S; Roberts R; Sachs HC; Suarez S; Tandon V; Uppoor RS
Pediatrics; 2008 Mar; 121(3):530-9. PubMed ID: 18310202
[TBL] [Abstract][Full Text] [Related]
34. Advances in paediatric pharmacokinetics.
Knibbe CA; Krekels EH; Danhof M
Expert Opin Drug Metab Toxicol; 2011 Jan; 7(1):1-8. PubMed ID: 21117982
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic changes in critical illness.
Boucher BA; Wood GC; Swanson JM
Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999
[TBL] [Abstract][Full Text] [Related]
36. [Pediatric pharmacy].
Pecar A; Wagner R
Med Monatsschr Pharm; 2010 Mar; 33(3):76-86. PubMed ID: 20355669
[No Abstract] [Full Text] [Related]
37. Pediatric pharmacokinetics.
Wagner J; Abdel-Rahman SM
Pediatr Rev; 2013 Jun; 34(6):258-69. PubMed ID: 23729775
[TBL] [Abstract][Full Text] [Related]
38. [Pharmacokinetic and metabolic studies in the development of drugs].
Vereczkey L
Acta Pharm Hung; 1995 Jul; 65(4):105-11. PubMed ID: 7572191
[TBL] [Abstract][Full Text] [Related]
39. Using ontogeny information to build predictive models for drug elimination.
Alcorn J; McNamara PJ
Drug Discov Today; 2008 Jun; 13(11-12):507-12. PubMed ID: 18549977
[TBL] [Abstract][Full Text] [Related]
40. Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: implications for ocular drug disposition.
Zhang T; Xiang CD; Gale D; Carreiro S; Wu EY; Zhang EY
Drug Metab Dispos; 2008 Jul; 36(7):1300-7. PubMed ID: 18411399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
